NCT02634437View on ClinicalTrials.gov

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

December 9, 2016

Study Completion Date

December 9, 2016

Conditions
Renal Function
Interventions
DRUG

Ulipristal acetate

Trial Locations (5)

32809

Orlando Clinical Research Center, Orlando

33104

Division of Clinical Pharmacology, University of Miami, Miami

33136

Clinical Pharmacology of Miami, Miami

55114

Prism Clinical Research, Saint Paul

65802

QPS Bio-Kinetic, Springfield

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT02634437 - Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects | Biotech Hunter | Biotech Hunter